These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26721675)

  • 21. Biased activity of soluble guanylyl cyclase: the Janus face of thymoquinone.
    Detremmerie C; Vanhoutte PM; Leung S
    Acta Pharm Sin B; 2017 Jul; 7(4):401-408. PubMed ID: 28752025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide.
    Zheng X; Ying L; Liu J; Dou D; He Q; Leung SW; Man RY; Vanhoutte PM; Gao Y
    Cardiovasc Res; 2011 Jun; 90(3):565-72. PubMed ID: 21248051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular nitric oxide: Beyond eNOS.
    Zhao Y; Vanhoutte PM; Leung SW
    J Pharmacol Sci; 2015 Oct; 129(2):83-94. PubMed ID: 26499181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble guanylyl cyclase: physiological role as an NO receptor and the potential molecular target for therapeutic application.
    Nakane M
    Clin Chem Lab Med; 2003 Jul; 41(7):865-70. PubMed ID: 12940510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cCMP and cUMP Across the Tree of Life: From cCMP and cUMP Generators to cCMP- and cUMP-Regulated Cell Functions.
    Seifert R
    Handb Exp Pharmacol; 2017; 238():3-23. PubMed ID: 28181008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide--the endothelium-derived relaxing factor and its role in endothelial functions.
    Bauer V; Sotníková R
    Gen Physiol Biophys; 2010 Dec; 29(4):319-40. PubMed ID: 21156995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of downstream target genes regulated by the nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate signal pathway in pulmonary hypertension.
    Zou L; Xu X; Zhai Z; Yang T; Jin J; Xiao F; Wang C
    J Int Med Res; 2016 Jun; 44(3):508-19. PubMed ID: 27048385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal nitric oxide synthase and its interaction with soluble guanylate cyclase is a key factor for the vascular dysfunction of experimental sepsis.
    Nardi GM; Scheschowitsch K; Ammar D; de Oliveira SK; Arruda TB; Assreuy J
    Crit Care Med; 2014 Jun; 42(6):e391-400. PubMed ID: 24717470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is next in nitric oxide research? From cardiovascular system to cancer biology.
    Bian K; Murad F
    Nitric Oxide; 2014 Dec; 43():3-7. PubMed ID: 25153032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent progress in the field of cIMP research.
    Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1045-7. PubMed ID: 27534403
    [No Abstract]   [Full Text] [Related]  

  • 34. From canonical to non-canonical cyclic nucleotides as second messengers: pharmacological implications.
    Seifert R; Schneider EH; Bähre H
    Pharmacol Ther; 2015 Apr; 148():154-84. PubMed ID: 25527911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
    Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
    Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling.
    Bellingham M; Evans TJ
    Cell Signal; 2007 Oct; 19(10):2183-93. PubMed ID: 17643962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in the nitric oxide-soluble guanylate cyclase system and natriuretic peptide receptor system in placentas of pregnant Dahl salt-sensitive rats.
    Takushima S; Nishi Y; Nonoshita A; Mifune H; Hirata R; Tanaka E; Doi R; Hori D; Kamura T; Ushijima K
    J Obstet Gynaecol Res; 2015 Apr; 41(4):540-50. PubMed ID: 25370989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daily red wine consumption improves vascular function by a soluble guanylyl cyclase-dependent pathway.
    Botden IP; Langendonk JG; Meima ME; Boomsma F; Seynhaeve AL; ten Hagen TL; Jan Danser AH; Sijbrands EJ
    Am J Hypertens; 2011 Feb; 24(2):162-8. PubMed ID: 21088673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammalian Nucleotidyl Cyclases and Their Nucleotide Binding Sites.
    Dove S
    Handb Exp Pharmacol; 2017; 238():49-66. PubMed ID: 27900607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.